DIUXF
Price:
$1.3672
Market Cap:
$107.70M
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of bio...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2020-05-29
Stock Exchange
PNK
Ticker
DIUXF
According to Diaceutics PLC’s latest financial reports and current stock price. The company's current PE Ratio is 136.72. This represents a change of -767.22% compared to the average of -20.49 of the last 4 quarters.
The mean historical PE Ratio of Diaceutics PLC over the last ten years is 116.68. The current 136.72 PE Ratio has changed 11.62% with respect to the historical average. Over the past ten years (40 quarters), DIUXF's PE Ratio was at its highest in in the January 2018 quarter at 105.09. The PE Ratio was at its lowest in in the June 2021 quarter at -79.05.
Average
116.68
Median
100.20
Minimum
-41.97
Maximum
393.56
Discovering the peaks and valleys of Diaceutics PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.68%
Maximum Annual PE Ratio = 393.56
Minimum Annual Increase = -35823.19%
Minimum Annual PE Ratio = -41.97
Year | PE Ratio | Change |
---|---|---|
2023 | -41.97 | -147.83% |
2022 | 87.75 | -42.50% |
2021 | 152.61 | -61.22% |
2020 | 393.56 | 139.68% |
2019 | 164.20 | 56.24% |
2018 | 105.09 | 4.88% |
2017 | 100.20 | 12.66% |
2016 | 88.94 | -35823.19% |
The current PE Ratio of Diaceutics PLC (DIUXF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
66.13
5-year avg
151.23
10-year avg
116.68
Diaceutics PLC’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diaceutics PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Diaceutics PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Diaceutics PLC's PE Ratio?
How is the PE Ratio calculated for Diaceutics PLC (DIUXF)?
What is the highest PE Ratio for Diaceutics PLC (DIUXF)?
What is the 3-year average PE Ratio for Diaceutics PLC (DIUXF)?
What is the 5-year average PE Ratio for Diaceutics PLC (DIUXF)?
How does the current PE Ratio for Diaceutics PLC (DIUXF) compare to its historical average?